tiprankstipranks
Trending News
More News >

YiChang HEC ChangJiang Pharmaceutical Advances in Merger Process

Story Highlights
  • YiChang HEC ChangJiang Pharmaceutical is progressing in its merger with Sunshine Lake Pharma.
  • Pre-Conditions (1) and (3) are fulfilled, with Pre-Condition (2) still pending in the merger process.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
YiChang HEC ChangJiang Pharmaceutical Advances in Merger Process

Don’t Miss TipRanks’ Half-Year Sale

YiChang HEC ChangJiang Pharmaceutical Co. Ltd. Class H ( (HK:1558) ) has issued an announcement.

YiChang HEC ChangJiang Pharmaceutical Co., Ltd. has announced the fulfilment of certain pre-conditions related to its proposed merger with Sunshine Lake Pharma Co., Ltd. The merger, structured as a merger by absorption, has met Pre-Conditions (1) and (3), involving necessary governmental approvals and shareholder approval. However, Pre-Condition (2), which pertains to the listing and vetting process with the Stock Exchange and SFC, is still pending. The completion of this merger is expected to impact the company’s operations and market positioning, with further announcements to be made as developments occur.

The most recent analyst rating on (HK:1558) stock is a Buy with a HK$13.80 price target. To see the full list of analyst forecasts on YiChang HEC ChangJiang Pharmaceutical Co. Ltd. Class H stock, see the HK:1558 Stock Forecast page.

More about YiChang HEC ChangJiang Pharmaceutical Co. Ltd. Class H

YiChang HEC ChangJiang Pharmaceutical Co., Ltd. is a pharmaceutical company based in the People’s Republic of China, focusing on the development and production of pharmaceutical products. It operates in the healthcare industry, with a market focus on providing medical solutions and products.

Average Trading Volume: 7,458,003

Technical Sentiment Signal: Strong Buy

Current Market Cap: HK$11.49B

For a thorough assessment of 1558 stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1